Answer
The safety and efficacy of KIMMTRAK (tebentafusp) in children under 18 years have not been established, and no data are available.
Sources for this answer
- KIMMTRAK (tebentafusp) 200 micrograms/ mL concentrate for solution for infusionImmunocore Limited · emc · SmPC §4.2 Posology and method of administration · Version 1Document updated
Sources checked